-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Sell on Aveanna Healthcare Hldgs, Raises Price Target to $5

Benzinga·05/09/2025 21:38:20
Listen to the news
UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Sell and raises the price target from $4.5 to $5.